FTC, Express Scripts Reach Landmark Settlement to Lower Insulin Prices
The Epoch Times
The FTC and Express Scripts reached a settlement requiring the pharmacy benefit manager to increase transparency and lower insulin prices.Summary
The Federal Trade Commission (FTC) and Express Scripts, Inc. have reached a landmark settlement resolving a lawsuit alleging that Express Scripts artificially inflated the prices of insulin. According to the FTC’s Feb. 4 statement, the settlement mandates that Express Scripts implement “fundamental changes to its business practices that increase transparency.” This action aims to address concerns about the affordability of insulin, a critical medication for millions of Americans.
(Source：The Epoch Times)